Stock Market & Financial News
Does Microsoft Stock Present an Opportunity via Teams Monetization?
MSFT reshapes Teams pricing by moving key features into Enterprise while adding new licenses, making renewal cycles key to its monetization strategy.
MSFT Plumas Bancorp (PLBC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Plumas Bancorp (PLBC) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
PLBC Invest $100,000 in These Dividend Stocks and Collect Passive Income for Life
Wages arrive on an employer's schedule. Dividends arrive on a corporate board's schedule and keep arriving whether markets are open or closed.
ARCC 2 Quantum Stocks That Could Challenge IonQ's Leadership
Despite its status as the largest pure-play quantum computing firm by market capitalization, IonQ Inc. NYSE: IONQ has proven not to be the most stable bet in recent weeks. Shares have fallen about 35% in the last month, and despite a strong Q1 2026 in many respects, the firm's losses per share are widening.
QMCO 
The Bearish Memory Thesis in MU & AI Research
@CharlesSchwab's Nate Peterson explains the bearish case for the memory market and why Micron's (MU) performance could shape the industry's outlook. He also discusses Apple's (AAPL) partnerships with AI research labs to examine how advances in AI model compression could affect future memory demand.
MU 
Pound Sterling Price News and Forecast: GBP/USD rallies as soft US PPI hits US Dollar
Pound Sterling Price News and Forecast: GBP/USD rallies as soft US PPI hits US Dollar
Bitcoin Giant Strategy Isn't Panicking—Unless BTC Crashes to $10K: CEO
The Bitcoin treasury giant will issue fresh preferred stock and resume buying once its Stretch shares climb back to par, CEO Phong Le said.
SpaceX Hits New Low as Stock Nears IPO Price
SpaceX stock is just about back to where it started when the company completed its record-setting IPO last month.
SPCX 
Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data
BIIB's Alzheimer's drug data presentation reaffirms a phase II setback as investors weigh plans to advance diranersen in phase III despite missed goals.
BIIB 
Cybersecurity ETF (BUG) Hits New 52-Week High
For investors seeking momentum, Global X Cybersecurity ETF BUG is probably on the radar. The fund just hit a 52-week high and is up 82.25% from its 52-week low price of $23.15/share.
BUG 
U.S. IPO Market Has More Room to Rally in H2 2026: ETFs Poised to Win
The next phase of the IPO rally could extend beyond tech mega-deals, driven by a more diversified pipeline, benefiting ETFs like FPX and IPO.
FPX 
BitMine made $46 million staking Ethereum then lost twice that betting on it
BitMine's push to turn one of the world's largest corporate Ethereum holdings into a source of recurring income generated nearly $46 million from staking last quarter. Yet a $92.1 million options loss overwhelmed those gains, while rising treasury costs and aggressive share issuance further weakened the economics for existing shareholders.
Cameco Resolves Cigar Lake Disruption: Are 2026 Targets on Track?
CCJ restarts Cigar Lake and McClean Lake operations, maintaining 2026 output targets after a temporary mill disruption.
CCJ 
J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook Raised
JNJ tops Q2 earnings and sales estimates, driven by key drug growth, and raises its 2026 outlook despite a slight MedTech sales miss.
JNJ 
ASML Q2: The Business Is Better Than Ever, The Stock Isn't
ASML Holding N.V. delivered a strong Q2, with €9.3B in sales and EPS of €7.59, beating expectations. ASML management raised 2026 guidance to €43–45B revenue and up to 56% gross margin, citing robust long-term demand visibility. Customer long-term agreements are reducing cyclicality, enhancing earnings quality, and supporting premium valuation.
ASML 
Wabash National Q2 Preview: The Downturn Will Take Longer To Turn Around
Wabash National Corporation faces ongoing industry downturns, with Q2 guidance indicating continued losses and only modest revenue stabilization. Backlog remains a key indicator; while up 20% y/y to $837 million, it is far below 2023 highs, signaling only a tentative recovery. Parts & services are outperforming, showing sequential and y/y growth with higher margins, but core transportation solutions volumes remain under pressure.
WNC 
Morgan Stanley Destroys Bear Case Against Nebius. Proves The 35% Plunge Was a Huge Mistake
Artificial intelligence stocks have spent much of this year whipsawing between optimism and doubt.
MGHL 
Loop Industries, Inc. (LOOP) Q1 2027 Earnings Call Transcript
Loop Industries, Inc. (LOOP) Q1 2027 Earnings Call Transcript
LOOP 
Storebrand ASA (SREDY) Q2 2026 Earnings Call Transcript
Storebrand ASA (SREDY) Q2 2026 Earnings Call Transcript
ASA 
Aehr Test Systems surge on earnings beat, strong guidance
Aehr Test Systems (NASDAQ:AEHR) shares jumped 30% after the semiconductor test and burn-in equipment provider reported fiscal fourth-quarter results that exceeded Wall Street expectations and provided a stronger-than-anticipated revenue outlook for fiscal 2027. The company posted adjusted earnings of $0.11 per diluted share for the quarter ended May 29, 2026, compared with analyst expectations for a loss of $0.01 per share.
AEHR 
Can Argan's Record Q1 Results Keep the Stock on Its Winning Path?
AGX delivers record Q1 results with soaring revenues, margins and backlog, as strong liquidity and power infrastructure demand support its growth outlook.
AGX 
Should You Buy, Sell or Hold ABBV Stock After Its 9% YTD Rise?
AbbVie ABBV stock has risen 8.9% so far this year as investor confidence strengthened in the company's post-Humira growth strategy. Despite Humira's U.S. patent expiry in 2023, AbbVie has successfully replaced much of the blockbuster's lost revenues with strong growth from Skyrizi and Rinvoq, easing concerns over its long-term earnings outlook.
ABBV 
TSLA Q2 Earnings Beat Likely: Why the Stock Still Isn't a Buy
Tesla may beat Q2 earnings estimates as deliveries and energy storage surge, but rich valuation, heavy AI spending and execution risks cloud the stock's appeal.
TSLA 
AGQ vs. ZSL: Betting on or Against Silver, Which 2x ETF Survives the Volatility?
ProShares Ultra Silver (NYSEARCA:AGQ) and ProShares UltraShort Silver (NYSEARCA:ZSL) look like mirror images: one bets 2x long on silver, the other 2x short.
AGQ 
Zuckerberg is a “Brilliant Gangster”: Dana White's Inside Look at the Meta Boardroom
UFC CEO Dana White has spent a year and a half watching Mark Zuckerberg operate from inside the boardroom, and his read on the man running Meta Platforms (NASDAQ:META | META Price Prediction) is worth noting.
DAN 
Apple chasing AI chip company deals, The Information reports
Apple is looking to buy chip companies to bolster its efforts to make server processors for running AI, The Information reported on Wednesday, citing people familiar with the matter.
AAPL 
Bitcoin hits $65K as US inflation data sparks three-week price high
Bitcoin's surge highlights its sensitivity to macroeconomic shifts, underscoring the potential volatility tied to future inflation data. Bitcoin hits $65K as US inflation data sparks three-week price high.
Plumas Bancorp (PLBC) Beats Q2 Earnings and Revenue Estimates
Plumas Bancorp (PLBC) came out with quarterly earnings of $1.41 per share, beating the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.05 per share a year ago.
PLBC 
Will Travelers Pull Off a Surprise This Earnings Season?
TRV's Q2 results may benefit from pricing, premium growth and higher investment income, though storm losses can weigh on profitability.
TRV 
Afry AB (AFXXF) Q2 2026 Earnings Call Transcript
Afry AB (AFXXF) Q2 2026 Earnings Call Transcript
AFXXF 
